Company Filing History:
1 out of 5,089 
1 out of 170 
1 out of 223 
Years Active: 2022
Title: Ahmed Ghannam: Innovator in Virus-Like Particle Technology
Introduction
Ahmed Ghannam is a notable inventor based in Strasbourg, France. He has made significant contributions to the field of biotechnology, particularly in the development of virus-like particles. His work has implications in various sectors, including pharmaceuticals and agriculture.
Latest Patents
Ahmed Ghannam holds a patent for "Virus-like particles and uses thereof." This invention relates to GFLV virus-like particles and their applications in diverse fields such as pharmaceuticals, agro, and veterinary areas. His innovative approach has the potential to enhance the effectiveness of treatments and products in these industries.
Career Highlights
Throughout his career, Ahmed has worked with prestigious institutions, including the Centre National de la Recherche Scientifique and the Université de Strasbourg. His experience in these organizations has allowed him to collaborate with leading experts in his field and contribute to groundbreaking research.
Collaborations
Some of his notable coworkers include Serge Muyldermans and Gérard Demangeat. Their collaborative efforts have further advanced the research and applications of virus-like particles.
Conclusion
Ahmed Ghannam is a distinguished inventor whose work in virus-like particle technology is paving the way for advancements in various fields. His contributions are essential for the future of biotechnology and its applications.